ArticleAlimentary pharmacology & therapeutics2022
Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.
Vivek C Goodoory et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled ittrialcites it